Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.69 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.69 |
| ▸ | EPOR | P19235 | 4/20 | 0.46 |
| ▸ | TSPO | P30536 | 5/20 | 0.39 |
| ▸ | BACE1 | P56817 | 3/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.37 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9877137 | 0.89 | ALOX5 (0.54) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL9877132 | 0.89 | ALOX5 (0.54) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL9877185 | 0.86 | ALOX5 (0.51) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL9877184 | 0.86 | ALOX5 (0.51) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL9877323 | 0.85 | ALOX5 (0.50) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL9877324 | 0.85 | ALOX5 (0.50) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL3899072 | 0.82 | ALOX5 (1.00) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL29808733 | 0.82 | ALOX5 (1.00) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL3903195 | 0.82 | ALOX5 (1.00) | ALOX5PTGS1PTGS2ALOX5APEPOR | |
| SCHEMBL9877152 | 0.80 | ALOX5 (0.45) | ALOX5PTGS1PTGS2ALOX5APEPOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0196184-B1 | ARYL DERIVATIVES | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-09-16 | — | — | EP | disclosed |
| US-5036157-A | Hydroxamic acid derivatives, lipoxygenase and cyclooxygenase inhibitors, anticoagulants, antiinflammatory agents | BURROUGHS WELLCOME CO. | 1991-07-30 | — | — | US | disclosed |
| US-4977188-A | Hydroamic acid derivatives | BURROUGHS WELLCOME CO. (US) | 1990-12-11 | — | — | US | disclosed |
| WO-1990001929-A1 | NEW MEDICAL USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-03-08 | — | — | WO | disclosed |
| US-4738986-A | CYCLOOXYGENASE, LIDOXYGENASE INHIBITORS | BURROUGHS WELLCOME CO. (US) | 1988-04-19 | — | — | US | disclosed |
| EP-0196184-A2 | Aryl derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-10-01 | — | — | EP | disclosed |